BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12

• Press Releases

  Volastra Therapeutics Expands Clinical Development Program Following Encouraging KIF18A Inhibitor Data and Appoints New Chief Medical Officer to Lead Clinical Strategy

  January 7, 2026

   · 

  5 min read
• Press Releases

  Kallyope Announces 2026 Strategic Priorities for Migraine and Metabolism Portfolio Based on Novel Neural Circuits Platform

  January 7, 2026

   · 

  5 min read
• Press Releases

  Merck to Complete Acquisition of Cidara Therapeutics

  January 7, 2026

   · 

  6 min read
• Press Releases

  Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3

  January 7, 2026

   · 

  3 min read
• Press Releases

  SAGA Diagnostics® Presents Real-World Pathlight™ MRD Data at ASCO GI 2026

  January 7, 2026

   · 

  4 min read
• Press Releases

  LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference

  January 7, 2026

   · 

  1 min read
• Press Releases

  TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

  January 7, 2026

   · 

  1 min read
• Press Releases

  Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

  January 7, 2026

   · 

  1 min read
• Press Releases

  Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference

  January 7, 2026

   · 

  1 min read
• Press Releases

  Merck Initiates Phase 3 KANDLELIT-007 Trial Evaluating Calderasib (MK-1084), an Investigational Oral KRAS G12C Inhibitor, in Combination With KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) in Certain Patients With Advanced NSCLC

  January 7, 2026

   · 

  19 min read